期刊文献+

法尼酯X受体上调肝细胞中成纤维细胞生长因子21的表达

Farnesoid X receptor upregulates fibroblast growth factor 21 expression in cultured liver cells
下载PDF
导出
摘要 目的研究法尼酯X受体(farnesoid X receptor,FXR)对成纤维细胞生长因子21(fibroblast growth factor,FGF21)表达的影响。方法用FXR特异性激动剂终浓度为0、50、100μmol/L的CDCA和0、1、5μmol/L的GW4064分别处理人肝癌细胞株HepG2和人胚胎肝细胞L02细胞后,用逆转录-聚合酶链法(RT-PCR)检测FXR特异性靶基因小异源二聚体配体(small heterodimer parterner,SHP)和FGF21 mRNA的表达变化,再用Western blot法检测FGF21蛋白表达水平的变化。结果用FXR特异性激动剂CDCA和GW4064刺激后,分别比较HepG2和L02细胞SHP与β-actin mRNART-PCR产物光密度比值,比值均明显增高(P<0.05),反应HepG2和L02细胞内SHP mRNA水平均明显升高,表明FXR在2种细胞中被激活;分别比较HepG2和L02细胞FGF21与β-actin RT-PCR产物光密度比值以及FGF21与β-actin蛋白光密度比值,比值均明显升高(P<0.05),表明FGF21 mRNA和蛋白水平均明显升高。结论激活的FXR可以上调FGF21的表达。 Objective To determine the effect of farnesoid X receptor(FXR) on the expression of fibroblast growth factor21(FGF21) in human hepatoblastoma HepG2 cells and hepatocyte L02 cells.Methods After HepG2 cells and L02 cells were treated with FXR agonist chenodesoxycholic acid(CDCA) at 0,50 or 100 μmol/L,or with another agonist GW4064 at 0,1 or 5 μmol/L respectively.The FXR specific target gene small heterodimer partner(SHP) and the FGF21 mRNA level were detected by reverse transcription-polymerase chain reaction(RT-PCR),and FGF21 protein level was determined by Western blotting.Results After treated with CDCA and GW4064,the mRNA expression of SHP was significantly increased in the treated HepG2 and L02 cells when compared with the untreated cells respectively(P0.05),which suggested that FXR was functionally activated in those cells.The mRNA and protein expressions of FGF21 were also increased in those treated cells(P0.05).Conclusion FXR receptor upregulates the expression of FGF21 in hepatocytes.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第9期912-915,共4页 Journal of Third Military Medical University
基金 国家自然科学基金(81070228) 重庆市自然科学基金(CSTC2007BB5050)~~
关键词 法尼酯X受体 成纤维细胞生长因子21 鹅脱氧胆酸 肥胖 Farnesoid X receptor fibroblast growth factor21 chenodesoxycholic acid obesity
  • 相关文献

参考文献20

  • 1Mokdad A H, Ford E S, Bowman B A, et al. Prevalence of obesity diabetes, and obesity-related health risk factors, 2001 [ J]. JAMA 2003, 289 ( 1 ) : 76 - 79.
  • 2Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver[ J ]. Biochim Biophys Acta, 2000, 1492(1 ): 203-206.
  • 3Kharitonenkov A, Shiyanova T L, Koester A, et al. FGF-21 as a novel metabolic regulator[J]. J Clin Invest, 2005, 115(6): 1627 - 1635.
  • 4Forman B M, Goode E, Chen J, et al. Identification of a nuclear receptor that is activated by farnesol metabolites [J]. Cell, 1995, 81 (5) : 687 - 693.
  • 5Zhang Y, Edwards P A. FXR signahng in metabohc disease [J]. FEBS Lett, 2008, 582(1) : 10-18.
  • 6Wente W, Efanov A M, Brenner M, et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regnlated kinase 1/2 and Akt signaling pathways[J]. Diabeties, 2006, 55 (9) : 2470 - 2478.
  • 7Kharitonenkov A, Wroblewski V J, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 [J]. Endocrinology, 2007, 148(2): 774-781.
  • 8Badman M K, Pissios P, Kermedy A R, et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states[J]. Cell Metab, 2007, 5 (6) :426 -437.
  • 9Coskun T, Bina H A, Schneider M A, et al. Fibroblast growth factor 21 corrects obesity in mice[J]. Endocrinology, 2008, 149(12) : 6018 -6027.
  • 10Xu J, Lloyd D J, Hale C, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice[ J]. Diabetes, 2009, 58 (1) : 250 - 259.

二级参考文献23

  • 1Kumar S N, Boss J M. Site A of the MCP-1 distal regulatory region functions as a transcriptional modulator through the transcription factor NF1[J]. Mol Immunol, 2000, 37(11): 623 -632.
  • 2Ahmed R A, Murao K, lmachi H, et al. c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells[J]. Endocrine, 2009, 35(2): 184-188.
  • 3Mukerjee R, Deshmane S L, Darbinian N, et al. St. John' s Wort protein, p27SJ, regulates the MCP-1 promoter[J]. Mol Immunol, 2008, 45 ( 15 ) : 4028 - 4035.
  • 4Ping D, Boekhoudt G, Zhang F, et al. Spl binding is critical for promoter assembly and aetivation of the MCP-1 gene by tumor necrosis factor[J]. J Biol Chem, 2000, 275(3) : 1708 -1714.
  • 5Claudel T, Sturm E, Duez H, et al. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element[J]. J Clin Invest, 2002, 109(7) : 961 -971.
  • 6Das A, Femandez-Zapico M E, Cao S, et al. Disruption of an SP2/KLF6 repression complex by SlIP is required for farnesoid X receptor-induced endothelial cell migration[J]. J Biol Chem, 2006, 281 (51): 39105 -39113.
  • 7He F, Li J, Mu Y, et al. Downregulation of endothelin-1 by famesoid X receptor in vascular endothelial cells[J]. Cire Res, 2006, 98(2) : 192 - 199.
  • 8Kim M S, Shigenaga J, Moser A, et al. Repression of farnesoid X receptor during the acute phase response[J]. J Biol Chem, 2003, 278 (11): 8988-8995.
  • 9Huber R M, Murphy K, Miao B, et al. Generation of multiple fame-sold-X-receptor isoforms through the use of ahemative promoters [ J ]. Gene, 2002, 290(1/2) : 35 -43.
  • 10Willson T M, Jones S A, Moore J T, et al. Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism[J]. MedResRev, 2001, 21(6):513-522.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部